The risk of xenozoonosis infections poses the greatest obstacle against the clinical application of a hybrid artificial liver support system (HALSS). Primary human hepatocytes are an ideal source for HALSS, but the shortage of human livers available for hepatocyte isolation limits this modality. To resolve this issue, we previously demonstrated the upregulation of hepatocyte-specific function by spheroid formation in polyurethane foam and by culturing with the histone deacetylase inhibitor, trichostatin A (TSA), in a human hepatoma cell line (Huh 7). In this article we analyze the gene expression profile using cDNA microarray (1281 genes) in spheroid formation or culturing with TSA in Huh 7 to determine the target genes in hepatocyte differentiation. In both the spheroid formation and in the culture with TSA, the Oct-3/4 transcription factor was upregulated more than twofold, while the early growth response-1 (EGR-1) transactivator was downregulated less than 0.5-fold. These results indicate that expressions of Oct-3/4 and EGR-1 may be key factors in the induction of hepatocyte differentiation in Huh 7.
GaoX.; BianW.; YangJ.; TangK.; KitaniH.; AtsumiT.; JingN.A role of N-cadherin in neuronal differentiation of embryonic carcinoma P19 cells.Biochem. Biophys. Res. Commun.284: 1098–1103; 2001.
7.
GerlachJ. C.; ZiemerR.; NeuhausP.Fulminant liver failure: Relevance of extracorporeal hybrid liver support systems.Int. J. Artif. Organs19: 7–13; 1996.
8.
GerlachJ. C.Development of a hybrid liver support system: A review.Int. J. Artif. Organs19: 645–654; 1996.
9.
HuangR. P.; LiuC.; FanY.; MercolaD.; AdamsonE. D.Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.Cancer Res.55: 5054–5062; 1995.
10.
HuangR. P.; FanY.; de-BelleI.; NiemeyerC.; GottardisM. M.; MercolaD.; AdamsonE. D.Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation.Int. J. Cancer72: 102–109; 1997.
11.
IjimaH.; MatsushitaT.; NakazawaK.; FujiiY.; FunatsuK.Hepatocyte spheroids in polyurethane forms: Functional analysis and application for a hybrid artificial liver.Tissue Eng.4: 213–226; 1998.
12.
KawaiH. F.; KanekoS.; HondaM.; ShirotaY.; KobayashiK.α-Fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis.Hepatology33: 676–691; 2001.
13.
KhaoustovV. I.; RisinD.; PellisN. R.; YoffeB.Microarray analysis of genes differentially expressed in HepG2 cells cultured in simulated microgravity: Preliminary report. In Vitro Cell Dev.Biol. Anim.37: 84–88; 2001.
14.
LeeW.Acute liver failure.N. Engl. J. Med.329: 1862–1872; 1994.
15.
Le TissierP.; StoyeJ. P.; TakeuchiY.; PatienceC.; WeissR. A.Two sets of human-tropic retrovirus (letter).Nature389: 681–682; 1997.
16.
LevinW. J.; PressM. F.; GaynorR. B.; SukhatmeV. P.; BooneT. C.; ReissmannP. T.; FiglinR. A.; HolmesE. C.; SouzaL. M.; SlamonD. J.Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.Oncogene11: 1261–1269; 1995.
17.
NiwaH.; MiyazakiJ.; SmithA. G.Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.Nat. Genet.24: 372–376; 2001.
18.
PatienceC.; TakeuchiY.; WeissR. A.Infection of human cells by an endogenous retrovirus of pigs.Nat. Med.5: 282–286; 1999.
19.
PopperH.; RothL.; GerinJ.; TennantB. C.; GerinJ. L.Hepatocarcinogenecity of the woodchuck hepatitis virus.Proc. Natl. Acad. Sci. USA84: 866–870; 1987.
20.
RozgaJ.; DemetriouA. A.Artificial liver: Evolution and perspectives.ASAIO J.41: 831–837; 1995.
ShinS. Y.; KimS. Y.; KimJ. H.; MinD. S.; KoJ.; KangU. G.; KimY. S.; KwonT. K.; HanM. Y.; KimY. H.; LeeY. H.Induction of early growth response-1 gene expression by calmodulin antagonist trifluoperazine through the activation of Elk-1 in human fibrosarcoma HT1080 cells.J. Biol. Chem.276: 7797–7805; 2001.
23.
TaborE.Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma.J. Med. Virol.42: 357–365; 1994.
24.
van der LaanL. J.; LockeyC.; GriffethB. C.; FrasierF. S.; WilsonC. A.; OnionsD. E.; HeringB. J.; LongZ.; OttoE.; TorbettB. E.; SalomonD. R.Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice.Nature407: 90–94; 2000.
25.
WatanabeF. D.; MullonC. J.; HewittW. R.; ArkadopoulosN.; KahakuE.; EguchiS.; KhaliliT.; ArnautW.; ShackletonC. R.; RozgaJ.; SolomonB.; DemetriouA. A.Clinical experience with a bioartificial liver in the treatment of severe liver failure: A phase I clinical study.Ann. Surg.225: 484–494; 1997.
26.
YamashitaY.; ShimadaM.; TsujitaE.; TanakaS.; IjimaH.; NakazawaK.; SakiyamaR.; FukudaJ.; UedaT.; FunatsuK.; SugimachiK.Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver.Cell Transplant.10: 717–722; 2001.
27.
YamashitaY.; ShimadaM.; TsujitaE.; ShirabeK.; IjimaH.; NakazawaK.; SakiyamaR.; FukudaJ.; FunatsuK.; SugimachiK.Efficacy of a larger version of the hybrid artificial liver support system using a polyurethane foam/spheroid packed-bed module in a warm ischemic liver failure pig model for preclinical experiments.Cell Transplant.12: 101–107; 2003.
28.
YamashitaY.; ShimadaM.; HarimotoN.; RikimaruT.; ShirabeK.; TanakaS.; SugimachiK.Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells.Int. J. Cancer103: 572–576; 2003.
